Quang P.

Quang X. Pham serves as the Chairman and Chief Executive Officer of Cadrenal Therapeutics, Inc., where the company is focused on developing tecarfarin, an innovative oral anticoagulant aimed at addressing unmet needs in anticoagulation therapy. Pham also holds a position on the Board of Directors for Cognition and has previous experience as a strategic advisor for a public life science financing corporation. Additionally, Pham founded Espero BioPharma, which specializes in therapeutics for cardiovascular diseases, and has held significant roles in various organizations, including D&R LATHIAN, Connexions Software, and Lathian Systems. Pham authored a book published by Penguin Random House, which received the Asian Heritage Book Award. Pham's earlier career includes experience in oncology sales with Genentech and active military service as a naval aviator in the United States Marine Corps. Quang X. Pham earned a BA in Economics from UCLA.